CBL enhances breast tumor formation by inhibiting tumor suppressive activity of TGF-β signaling

J. M. Kang, S. Park, S. J. Kim, H. Y. Hong, Jeong Joon, H. S. Kim, S. J. Kim

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Casitas B-lineage lymphoma (CBL) protein family functions as multifunctional adaptor proteins and E3 ubiquitin ligases that are implicated as regulators of signaling in various cell types. Recent discovery revealed mutations of proto-oncogenic CBL in the linker region and RING finger domain in human acute myeloid neoplasm, and these transforming mutations induced carcinogenesis. However, the adaptor function of CBL mediated signaling pathway during tumorigenesis has not been well characterized. Here, we show that CBL is highly expressed in breast cancer cells and significantly inhibits transforming growth factor-β (TGF-β) tumor suppressive activity. Knockdown of CBL expression resulted in the increased expression of TGF-β target genes, PAI-I and CDK inhibitors such as p15 INK4b and p21 Cip1. Furthermore, we demonstrate that CBL is frequently overexpressed in human breast cancer tissues, and the loss of CBL decreases the tumorigenic activity of breast cancer cells in vivo. CBL directly binds to Smad3 through its proline-rich motif, thereby preventing Smad3 from interacting with Smad4 and blocking nuclear translocation of Smad3. CBL-b, one of CBL protein family, also interacted with Smad3 and knockdown of both CBL and CBL-b further enhanced TGF-β transcriptional activity. Our findings provide evidence for a previously undescribed mechanism by which oncogenic CBL can block TGF-β tumor suppressor activity.

Original languageEnglish
Pages (from-to)5123-5131
Number of pages9
JournalOncogene
Volume31
Issue number50
DOIs
Publication statusPublished - 2012 Dec 13

Fingerprint

Transforming Growth Factors
Lymphoma
Breast Neoplasms
Neoplasms
Oncogene Protein v-cbl
Carcinogenesis
RING Finger Domains
Mutation
Ubiquitin-Protein Ligases
Proline

All Science Journal Classification (ASJC) codes

  • Molecular Biology
  • Genetics
  • Cancer Research

Cite this

Kang, J. M., Park, S., Kim, S. J., Hong, H. Y., Joon, J., Kim, H. S., & Kim, S. J. (2012). CBL enhances breast tumor formation by inhibiting tumor suppressive activity of TGF-β signaling. Oncogene, 31(50), 5123-5131. https://doi.org/10.1038/onc.2012.18
Kang, J. M. ; Park, S. ; Kim, S. J. ; Hong, H. Y. ; Joon, Jeong ; Kim, H. S. ; Kim, S. J. / CBL enhances breast tumor formation by inhibiting tumor suppressive activity of TGF-β signaling. In: Oncogene. 2012 ; Vol. 31, No. 50. pp. 5123-5131.
@article{90d09fa9657b41d6a96bcea5f8b4d5ad,
title = "CBL enhances breast tumor formation by inhibiting tumor suppressive activity of TGF-β signaling",
abstract = "Casitas B-lineage lymphoma (CBL) protein family functions as multifunctional adaptor proteins and E3 ubiquitin ligases that are implicated as regulators of signaling in various cell types. Recent discovery revealed mutations of proto-oncogenic CBL in the linker region and RING finger domain in human acute myeloid neoplasm, and these transforming mutations induced carcinogenesis. However, the adaptor function of CBL mediated signaling pathway during tumorigenesis has not been well characterized. Here, we show that CBL is highly expressed in breast cancer cells and significantly inhibits transforming growth factor-β (TGF-β) tumor suppressive activity. Knockdown of CBL expression resulted in the increased expression of TGF-β target genes, PAI-I and CDK inhibitors such as p15 INK4b and p21 Cip1. Furthermore, we demonstrate that CBL is frequently overexpressed in human breast cancer tissues, and the loss of CBL decreases the tumorigenic activity of breast cancer cells in vivo. CBL directly binds to Smad3 through its proline-rich motif, thereby preventing Smad3 from interacting with Smad4 and blocking nuclear translocation of Smad3. CBL-b, one of CBL protein family, also interacted with Smad3 and knockdown of both CBL and CBL-b further enhanced TGF-β transcriptional activity. Our findings provide evidence for a previously undescribed mechanism by which oncogenic CBL can block TGF-β tumor suppressor activity.",
author = "Kang, {J. M.} and S. Park and Kim, {S. J.} and Hong, {H. Y.} and Jeong Joon and Kim, {H. S.} and Kim, {S. J.}",
year = "2012",
month = "12",
day = "13",
doi = "10.1038/onc.2012.18",
language = "English",
volume = "31",
pages = "5123--5131",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "50",

}

Kang, JM, Park, S, Kim, SJ, Hong, HY, Joon, J, Kim, HS & Kim, SJ 2012, 'CBL enhances breast tumor formation by inhibiting tumor suppressive activity of TGF-β signaling', Oncogene, vol. 31, no. 50, pp. 5123-5131. https://doi.org/10.1038/onc.2012.18

CBL enhances breast tumor formation by inhibiting tumor suppressive activity of TGF-β signaling. / Kang, J. M.; Park, S.; Kim, S. J.; Hong, H. Y.; Joon, Jeong; Kim, H. S.; Kim, S. J.

In: Oncogene, Vol. 31, No. 50, 13.12.2012, p. 5123-5131.

Research output: Contribution to journalArticle

TY - JOUR

T1 - CBL enhances breast tumor formation by inhibiting tumor suppressive activity of TGF-β signaling

AU - Kang, J. M.

AU - Park, S.

AU - Kim, S. J.

AU - Hong, H. Y.

AU - Joon, Jeong

AU - Kim, H. S.

AU - Kim, S. J.

PY - 2012/12/13

Y1 - 2012/12/13

N2 - Casitas B-lineage lymphoma (CBL) protein family functions as multifunctional adaptor proteins and E3 ubiquitin ligases that are implicated as regulators of signaling in various cell types. Recent discovery revealed mutations of proto-oncogenic CBL in the linker region and RING finger domain in human acute myeloid neoplasm, and these transforming mutations induced carcinogenesis. However, the adaptor function of CBL mediated signaling pathway during tumorigenesis has not been well characterized. Here, we show that CBL is highly expressed in breast cancer cells and significantly inhibits transforming growth factor-β (TGF-β) tumor suppressive activity. Knockdown of CBL expression resulted in the increased expression of TGF-β target genes, PAI-I and CDK inhibitors such as p15 INK4b and p21 Cip1. Furthermore, we demonstrate that CBL is frequently overexpressed in human breast cancer tissues, and the loss of CBL decreases the tumorigenic activity of breast cancer cells in vivo. CBL directly binds to Smad3 through its proline-rich motif, thereby preventing Smad3 from interacting with Smad4 and blocking nuclear translocation of Smad3. CBL-b, one of CBL protein family, also interacted with Smad3 and knockdown of both CBL and CBL-b further enhanced TGF-β transcriptional activity. Our findings provide evidence for a previously undescribed mechanism by which oncogenic CBL can block TGF-β tumor suppressor activity.

AB - Casitas B-lineage lymphoma (CBL) protein family functions as multifunctional adaptor proteins and E3 ubiquitin ligases that are implicated as regulators of signaling in various cell types. Recent discovery revealed mutations of proto-oncogenic CBL in the linker region and RING finger domain in human acute myeloid neoplasm, and these transforming mutations induced carcinogenesis. However, the adaptor function of CBL mediated signaling pathway during tumorigenesis has not been well characterized. Here, we show that CBL is highly expressed in breast cancer cells and significantly inhibits transforming growth factor-β (TGF-β) tumor suppressive activity. Knockdown of CBL expression resulted in the increased expression of TGF-β target genes, PAI-I and CDK inhibitors such as p15 INK4b and p21 Cip1. Furthermore, we demonstrate that CBL is frequently overexpressed in human breast cancer tissues, and the loss of CBL decreases the tumorigenic activity of breast cancer cells in vivo. CBL directly binds to Smad3 through its proline-rich motif, thereby preventing Smad3 from interacting with Smad4 and blocking nuclear translocation of Smad3. CBL-b, one of CBL protein family, also interacted with Smad3 and knockdown of both CBL and CBL-b further enhanced TGF-β transcriptional activity. Our findings provide evidence for a previously undescribed mechanism by which oncogenic CBL can block TGF-β tumor suppressor activity.

UR - http://www.scopus.com/inward/record.url?scp=84871244194&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84871244194&partnerID=8YFLogxK

U2 - 10.1038/onc.2012.18

DO - 10.1038/onc.2012.18

M3 - Article

VL - 31

SP - 5123

EP - 5131

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 50

ER -